Surfactant protein D increases phagocytosis of hypocapsular Cryptococcus neoformans by murine macrophages and enhances fungal survival

Infection and Immunity

Volumn 77, Issue 7, 2009, Pages 2783-2794

  Geunes Boyer, Scarlett ^a   Oliver, Timothy N ^a   Janbon, Guilhem ^c   Lodge, Jennifer K ^b   Heitman, Joseph ^a   Perfect, John R ^a   Wright, Jo Rae ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

SURFACTANT PROTEIN A; SURFACTANT PROTEIN D;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FUNGAL STRAIN; IMMUNE RESPONSE; MACROPHAGE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING;

ANIMALS; CELL LINE; COLONY COUNT, MICROBIAL; CRYPTOCOCCUS NEOFORMANS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROBIAL VIABILITY; PHAGOCYTOSIS; PROTEIN BINDING; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D;

EID: 67650093016     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00088-09     Document Type: Article

References (62)

1. Allen, M., A. Laederach, P. Reilly, and R. Mason. 2001. Polysaccharide recognition by surfactant protein D: novel interactions of a C-type lectin with nonterminal glucosyl residues. Biochemistry 40:7789-7798.
2. Allen, M., D. Voelker, and R. Mason. 2001. Interactions of surfactant proteins A and D with Saccharomyces cerevisiae and Aspergillus fumigatus. Infect. Immun. 69:2037-2044.
3. Alvarez, M., and A. Casadevall. 2006. Phagosome extrusion and host-cell survival after Cryptococcus neoformans phagocytosis by macrophages. Curr. Biol. 16:2161-2165.
4. Atochina, E., A. Gow, J. Beck, A. Haczku, A. Inch, H. Kadire, Y. Tomer, C. Davis, A. Preston, F. Poulain, S. Hawgood, and M. Beers. 2004. Delayed clearance of Pneumocystis carinii infection, increased inflammation, and altered nitric oxide metabolism in lungs of surfactant protein-D knockout mice. J. Infect. Dis. 189:1528-1539.
5. Banks, I., C. Specht, M. Donlin, K. Gerik, S. Levitz, and J. Lodge. 2005. A chitin synthase and its regulator protein are critical for chitosan production and growth of the fungal pathogen Cryptococcus neoformans. Eukaryot. Cell 4:1902-1912.
6. Barr, F., H. Pedigo, T. Johnson, and V. Shepherd. 2000. Surfactant protein-A enhances uptake of respiratory syncytial virus by monocytes and U937 macrophages. Am. J. Respir. Cell Mol. Biol. 23:586-592.
7. Bolaños, B., and T. Mitchell. 1989. Phagocytosis of Cryptococcus neoformans by rat alveolar macrophages. J. Med. Vet. Mycol. 27:203-217.
8. Charlier, C., K. Nielsen, S. Daou, M. Brigitte, F. Chretien, and F. Dromer. 2009. Evidence for a role of monocytes in dissemination and brain invasion by Cryptococcus neoformans. Infect. Immun. 77:120-127.
9. Chen, S., M. Stins, S. Huang, Y. Chen, K. Kwon-Chung, Y. Chang, K. Kim, K. Suzuki, and A. Jong. 2003. Cryptococcus neoformans induces alterations in the cytoskeleton of human brain microvascular endothelial cells. J. Med. Microbiol. 52:961-970.
10. Collins, H., and G. Bancroft. 1991. Encapsulation of Cryptococcus neoformans impairs antigen-specific T-cell responses. Infect. Immun. 59:3883-3888.
11. Crouch, E., B. McDonald, K. Smith, T. Cafarella, B. Seaton, and J. Head. 2006. Contributions of phenylalanine 335 to ligand recognition by human surfactant protein D: ring interactions with SP-D ligands. J. Biol. Chem. 281:18008-18014.
12. Crouch, E., K. Smith, B. McDonald, D. Briner, B. Linders, J. McDonald, U. Holmskov, J. Head, and K. Hartshorn. 2006. Species differences in the carbohydrate binding preferences of surfactant protein D. Am. J. Respir. Cell Mol. Biol. 35:84-94.
13. Davies, S., D. Clifford, J. Hoidal, and J. Repine. 1982. Opsonic requirements for the uptake of Cryptococcus neoformans by human polymorphonuclear leukocytes and monocytes. J. Infect. Dis. 145:870-874.
14. Dong, Q., and J. Wright. 1998. Degradation of surfactant protein D by alveolar macrophages. Am. J. Physiol. 274:L97-105.
15. Dong, Z., L. Jackson, and J. Murphy. 1999. Mechanisms for induction of L-selectin loss from T lymphocytes by a cryptococcal polysaccharide, glucuronoxylomannan. Infect. Immun. 67:220-229.
16. Dong, Z., and J. Murphy. 1997. Cryptococcal polysaccharides bind to CD18 on human neutrophils. Infect. Immun. 65:557-563.
17. Dong, Z., and J. Murphy. 1996. Cryptococcal polysaccharides induce Lselectin shedding and tumor necrosis factor receptor loss from the surface of human neutrophils. J. Clin. Investig. 97:689-698.
18. Dong, Z., and J. Murphy. 1993. Mobility of human neutrophils in response to Cryptococcus neoformans cells, culture filtrate antigen, and individual components of the antigen. Infect. Immun. 61:5067-5077.
19. Douglas, C. 2001. Fungal beta(1,3)-D-glucan synthesis. Med. Mycol. 39(Suppl. 1):55-66.
20. Fisher, J., V. Sheftelyevich, Y. Ho, S. Fligiel, F. McCormack, T. Korfhagen, J. Whitsett, and M. Ikegami. 2000. Pulmonary-specific expression of SP-D corrects pulmonary lipid accumulation in SP-D gene-targeted mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 278:L365-373.
21. Fraser, J., S. Giles, E. Wenink, S. Geunes-Boyer, J. Wright, S. Diezmann, A. Allen, J. Stajich, F. Dietrich, J. Perfect, and J. Heitman. 2005. Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak. Nature 437:1360-1364.
22. García-Rivera, J., Y. Chang, K. Kwon-Chung, and A. Casadevall. 2004. Cryptococcus neoformans CAP59 (or Cap59p) is involved in the extracellular trafficking of capsular glucuronoxylomannan. Eukaryot. Cell 3:385-392.
23. Gardai, S., Y. Xiao, M. Dickinson, J. Nick, D. Voelker, K. Greene, and P. Henson. 2003. By binding SIRPα or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 115:13-23.
24. Gates, M., P. Thorkildson, and T. Kozel. 2004. Molecular architecture of the Cryptococcus neoformans capsule. Mol. Microbiol. 52:13-24.
25. Giannoni, E., T. Sawa, L. Allen, J. Wiener-Kronish, and S. Hawgood. 2006. Surfactant proteins A and D enhance pulmonary clearance of Pseudomonas aeruginosa. Am. J. Respir. Cell Mol. Biol. 34:704-710.
26. Giles, S., A. Zaas, M. Reidy, J. Perfect, and J. Wright. 2007. Cryptococcus neoformans is resistant to surfactant protein A mediated host defense mechanisms. PLoS ONE 2:e1370.
27. Gross, N., P. Camner, M. Chinchilla, and C. Jarstrand. 1998. In vitro effect of lung surfactant on alveolar macrophage defence mechanisms against Cryptococcus neoformans. Mycopathologia 144:21-27.
28. James, P., R. Cherniak, R. Jones, C. Stortz, and E. Reiss. 1990. Cell-wall glucans of Cryptococcus neoformans Cap 67. Carbohydr. Res. 198:23-38.
29. Kozel, T., and E. Gotschlich. 1982. The capsule of Cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages. J. Immunol. 129:1675-1680.
30. Kudo, K., H. Sano, H. Takahashi, K. Kuronuma, S. Yokota, N. Fujii, K. Shimada, I. Yano, Y. Kumazawa, D. Voelker, S. Abe, and Y. Kuroki. 2004. Pulmonary collectins enhance phagocytosis of Mycobacterium avium through increased activity of mannose receptor. J. Immunol. 172:7592-7602.
31. Lee, S., Y. Kress, M. Zhao, D. Dickson, and A. Casadevall. 1995. Cryptococcus neoformans survive and replicate in human microglia. Lab. Investig. 73:871-879.
32. LeVine, A., J. Elliott, J. Whitsett, A. Srikiatkhachorn, E. Crouch, N. DeSilva, and T. Korfhagen. 2004. Surfactant protein-d enhances phagocytosis and pulmonary clearance of respiratory syncytial virus. Am. J. Respir. Cell Mol. Biol. 31:193-199.
33. Levitz, S., and D. DiBenedetto. 1989. Paradoxical role of capsule in murine bronchoalveolar macrophage-mediated killing of Cryptococcus neoformans. J. Immunol. 142:659-665.
34. Levitz, S., S. Nong, M. Mansour, C. Huang, and C. Specht. 2001. Molecular characterization of a mannoprotein with homology to chitin deacetylases that stimulates T cell responses to Cryptococcus neoformans. Proc. Natl. Acad. Sci. USA 98:10422-10427.
35. Levitz, S., S. Nong, K. Seetoo, T. Harrison, R. Speizer, and E. Simons. 1999. Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages. Infect. Immun. 67:885-890.
36. Levitz, S., and C. Specht. 2006. The molecular basis for the immunogenicity of Cryptococcus neoformans mannoproteins. FEMS Yeast Res. 6:513-524.
37. Lu, J., A. Willis, and K. Reid. 1992. Purification, characterization and cDNA cloning of human lung surfactant protein D. Biochem. J. 284:795-802.
38. Luberto, C., B. Martinez-Marino, D. Taraskiewicz, B. Bolanos, P. Chitano, D. L. Toffaletti, G. M. Cox, J. R. Perfect, Y. A. Hannun, E. Balish, and M. Del Poeta. 2003. Identification of App1 as a regulator of phagocytosis and virulence of Cryptococcus neoformans. J. Clin. Investig. 112:1080-1094.
39. Ma, H., J. Croudace, D. Lammas, and R. May. 2006. Expulsion of live pathogenic yeast by macrophages. Curr. Biol. 16:2156-2160.
40. Madan, T., U. Kishore, M. Singh, P. Strong, H. Clark, E. Hussain, K. Reid, and P. Sarma. 2001. Surfactant proteins A and D protect mice against pulmonary hypersensitivity induced by Aspergillus fumigatus antigens and allergens. J. Clin. Investig. 107:467-475.
41. Madan, T., U. Kishore, M. Singh, P. Strong, E. Hussain, K. Reid, and P. Sarma. 2001. Protective role of lung surfactant protein D in a murine model of invasive pulmonary aspergillosis. Infect. Immun. 69:2728-2731.
42. McFadden, D., B. Fries, F. Wang, and A. Casadevall. 2007. Capsule structural heterogeneity and antigenic variation in Cryptococcus neoformans. Eukaryot. Cell 6:1464-1473.
43. McIntosh, J., S. Mervin-Blake, E. Conner, and J. Wright. 1996. Surfactant protein A protects growing cells and reduces TNF-alpha activity from LPS-stimulated macrophages. Am. J. Physiol. 271:L310-L319.
44. Moyrand, F., T. Fontaine, and G. Janbon. 2007. Systematic capsule gene disruption reveals the central role of galactose metabolism on Cryptococcus neoformans virulence. Mol. Microbiol. 64:771-781.
45. Nelson, R., B. Pryor, and J. Lodge. 2003. Sequence length required for homologous recombination in Cryptococcus neoformans. Fungal Genet. Biol. 38:1-9.
46. Pericolini, E., E. Cenci, C. Monari, M. De Jesus, F. Bistoni, A. Casadevall, and A. Vecchiarelli. 2006. Cryptococcus neoformans capsular polysaccharide component galactoxylomannan induces apoptosis of human T-cells through activation of caspase-8. Cell. Microbiol. 8:267-275.
47. Pikaar, J., W. Voorhout, L. van Golde, J. Verhoef, J. Van Strijp, and J. van Iwaarden. 1995. Opsonic activities of surfactant proteins A and D in phagocytosis of gram-negative bacteria by alveolar macrophages. J. Infect. Dis. 172:481-489.
48. Reese, A., A. Yoneda, J. Breger, A. Beauvais, H. Liu, C. Griffith, I. Bose, M. Kim, C. Skau, S. Yang, J. Sefko, M. Osumi, J. Latge, E. Mylonakis, and T. Doering. 2007. Loss of cell wall alpha(1-3) glucan affects Cryptococcus neoformans from ultrastructure to virulence. Mol. Microbiol. 63:1385-1398.
49. Santangelo, R., H. Zoellner, T. Sorrell, C. Wilson, C. Donald, J. Djordjevic, Y. Shounan, and L. Wright. 2004. Role of extracellular phospholipases and mononuclear phagocytes in dissemination of cryptococcosis in a murine model. Infect. Immun. 72:2229-2239.
50. Schelenz, S., R. Malhotra, R. B. Sim, U. Holmskov, and G. J. Bancroft. 1995. Binding of host collectins to the pathogenic yeast Cryptococcus neoformans: human surfactant protein D acts as an agglutinin for acapsular yeast cells. Infect. Immun. 63:3360-3366.
51. Small, J., and T. Mitchell. 1989. Strain variation in antiphagocytic activity of capsular polysaccharides from Cryptococcus neoformans serotype A. Infect. Immun. 57:3751-3756.
52. Strong, P., K. Reid, and H. Clark. 2002. Intranasal delivery of a truncated recombinant human SP-D is effective at down-regulating allergic hypersensitivity in mice sensitized to allergens of Aspergillus fumigatus. Clin. Exp. Immunol. 130:19-24.
53. Syme, R., T. Bruno, T. Kozel, and C. Mody. 1999. The capsule of Cryptococcus neoformans reduces T-lymphocyte proliferation by reducing phagocytosis, which can be restored with anticapsular antibody. Infect. Immun. 67:4620-4627.
54. Tucker, S., and A. Casadevall. 2002. Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm. Proc. Natl. Acad. Sci. USA 99:3165-3170.
55. van de Wetering, J., F. Coenjaerts, A. Vaandrager, L. van Golde, and J. Batenburg. 2004. Aggregation of Cryptococcus neoformans by surfactant protein D is inhibited by its capsular component glucuronoxylomannan. Infect. Immun. 72:145-153.
56. van Furth, R., I. Elzenga-Claasen, M. van Schadewijk-Nieuwstad, M. Diesselhoff-den Dulk, H. Toivonen, and T. Rytömaa. 1987. Cell kinetic analysis of a murine macrophage cell line. Eur. J. Cell Biol. 44:93-96.
57. Vecchiarelli, A. 2000. Immunoregulation by capsular components of Cryptococcus neoformans. Med. Mycol. 38:407-417.
58. Walenkamp, A. M., A. F. Verheul, J. Scharringa, and I. M. Hoepelman. 1999. Pulmonary surfactant protein A binds to Cryptococcus neoformans without promoting phagocytosis. Eur. J. Clin. Investig. 29:83-92.
59. Wert, S., M. Yoshida, A. LeVine, M. Ikegami, T. Jones, G. Ross, J. Fisher, T. Korfhagen, and J. Whitsett. 2000. Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. Proc. Natl. Acad. Sci. USA 97:5972-5977.
60. Wright, J. 2005. Immunoregulatory functions of surfactant proteins. Nat. Rev. Immunol. 5:58-68.
61. Yauch, L., J. Lam, and S. Levitz. 2006. Direct inhibition of T-cell responses by the Cryptococcus capsular polysaccharide glucuronoxylomannan. PLoS Pathog. 2:e120.
62. Zaragoza, O., C. Chrisman, M. Castelli, S. Frases, M. Cuenca-Estrella, J. Rodríguez-Tudela, and A. Casadevall. 2008. Capsule enlargement in Cryptococcus neoformans confers resistance to oxidative stress suggesting a mechanism for intracellular survival. Cell. Microbiol. 10:2043-2057.